Overview
Access to capital is a primary consideration for strategic planning for health and life sciences companies. Providers face persistent demands for additional resources to update and replace technology, install and expand information systems, and otherwise stay competitive. In addition, innovative technology companies have the promise to transform care delivery and offer lucrative investment opportunities. Our corporate venture and health care innovation attorneys, consultants and professionals represent businesses and investors who shape our rapidly evolving health care landscape. We represent buyers and sellers at all stages of development. We represent notable brands and small and mid-sized companies — including institutions operating smaller corporate venture programs or making targeted strategic investments. We help clients with strategic affiliations and private capital transactions, and we support clients as they evaluate whether establishing a corporate venture program is the right strategy for their business. We have represented numerous buyers and sellers involved in regional and national provider roll-up transactions, and we understand the regulatory challenges associated with structuring these types of deals. We’ve also represented startups and private equity seeking to disrupt the health care economy by developing new patient care delivery models, including retail and e-technology models. If you're a startup tech company with an innovative health solution that promises to disrupt the market, we understand your need for venture capital funding or plans for an IPO. If you're an investment firm, we understand the need for your investments to secure a high return. We partner with you to develop your strategy and advance your goals.